Literature DB >> 20379613

Upregulation of SPRR3 promotes colorectal tumorigenesis.

Dong-Hyung Cho1, Yoon Kyung Jo, Seon Ae Roh, Young-Soon Na, Tae Won Kim, Se Jin Jang, Yong Sung Kim, Jin Cheon Kim.   

Abstract

Hereditary colorectal cancer develops through a series of well-defined genetic and histological changes. However, elucidation of the canonical pathway based on hereditary colorectal cancer has not provided a clear explanation of the molecular mechanisms of sporadic colorectal cancer. To identify the alterative pathways involved in sporadic colorectal tumorigenesis, we performed gene expression analysis in patients with sporadic colorectal tumors. A comparison analysis of gene expression profiles revealed a pattern of upregulation of small proline rich repeat protein 3 (SPRR3) in tumor samples. SPRR3 has previously been reported to be downregulated in esophageal cancer. However, in the present study, we observed that SPRR3 was strongly upregulated in 31 of 35 samples of sporadic colorectal tumors (88%). We also determined that overexpression of SPRR3 not only accelerates colorectal cancer cell proliferation but also is associated with lymphovascular invasion in colorectal cancer. Moreover, AKT was activated and p53 levels were decreased in cells that overexpressed SPRR3. In contrast to the pattern seen in esophageal cancer, these results suggest that increased expression of SPRR3 is involved in colorectal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379613      PMCID: PMC2896463          DOI: 10.2119/molmed.2009.00187

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  36 in total

1.  Genomic structure, chromosome mapping and expression analysis of the human AXIN2 gene.

Authors:  X Dong; R S Seelan; C Qian; M Mai; W Liu
Journal:  Cytogenet Cell Genet       Date:  2001

2.  A small proline-rich protein, SPRR1, is upregulated early during tobacco smoke-induced squamous metaplasia in rat nasal epithelia.

Authors:  J Tesfaigzi; J Th'ng; J A Hotchkiss; J R Harkema; P S Wright
Journal:  Am J Respir Cell Mol Biol       Date:  1996-05       Impact factor: 6.914

3.  Decreased expression of SPRR3 in Chinese human oesophageal cancer.

Authors:  B S Chen; M R Wang; Y Cai; X Xu; Z X Xu; Y L Han; M Wu
Journal:  Carcinogenesis       Date:  2000-12       Impact factor: 4.944

4.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 6.  Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.

Authors:  Jiyong Liang; Joyce M Slingerland
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

7.  Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis.

Authors:  Junwei Fan; Zhihai Peng; Chongzhi Zhou; Guoqiang Qiu; Huamei Tang; Yuhao Sun; Xiaoliang Wang; Qiang Li; Xiangdong Le; Keping Xie
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

Review 8.  Wnt signaling inside the nucleus.

Authors:  Miki Shitashige; Setsuo Hirohashi; Tesshi Yamada
Journal:  Cancer Sci       Date:  2008-01-02       Impact factor: 6.716

9.  Regulation of the atheroma-enriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction.

Authors:  Amy L Pyle; James B Atkinson; Ambra Pozzi; Jeff Reese; Beate Eckes; Jeffrey M Davidson; Dan L Crimmins; Pampee P Young
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

10.  National cancer incidence for the year 2002 in Korea.

Authors:  Hai-Rim Shin; Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Seon-Hee Yim; Joohon Sung; Sun-Won Seo; Ki-Young Kim; Sang-Yi Lee; In-Sik Kong; In Kyoung Hwang; Choong Won Lee; Ze-Hong Woo; Tae-Yong Lee; Jin-Su Choi; Cheol-In Yoo; Jong-Myon Bae; Keun-Young Yoo
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

View more
  19 in total

1.  Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.

Authors:  Amanda K Segedy; Amy L Pyle; Bin Li; Youmin Zhang; Vladimir R Babaev; Parmjit Jat; Sergio Fazio; James B Atkinson; MacRae F Linton; Pampee P Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

2.  Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Kohei Yamakawa; Michiyo Koyanagi-Aoi; Keiichiro Uehara; Atsuhiro Masuda; Hiroaki Yanagimoto; Hirochika Toyama; Takumi Fukumoto; Yuzo Kodama; Takashi Aoi
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.

Authors:  Gemma Mayol; José I Martín-Subero; José Ríos; Ana Queiros; Marta Kulis; Mariona Suñol; Manel Esteller; Soledad Gómez; Idoia Garcia; Carmen de Torres; Eva Rodríguez; Patricia Galván; Jaume Mora; Cinzia Lavarino
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

4.  Small proline-rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage-induced apoptosis.

Authors:  Aiping Luo; Hongyan Chen; Fang Ding; Yu Zhang; Mingrong Wang; Zefen Xiao; Zhihua Liu
Journal:  Mol Oncol       Date:  2013-06-13       Impact factor: 7.449

5.  Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme.

Authors:  Qingyang Liu; Chuanbao Zhang; Guofo Ma; Quangeng Zhang
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

6.  Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.

Authors:  Jin Cheon Kim; Ye Jin Ha; Ka Hee Tak; Seon Ae Roh; Chan Wook Kim; Tae Won Kim; Seon-Kyu Kim; Seon-Young Kim; Dong-Hyung Cho; Yong Sung Kim
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

7.  Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations.

Authors:  Samuel Backman; Rajani Maharjan; Alberto Falk-Delgado; Joakim Crona; Kenko Cupisti; Peter Stålberg; Per Hellman; Peyman Björklund
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

8.  Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancer.

Authors:  J C Kim; Y J Ha; S A Roh; E Y Choi; Y S Yoon; K P Kim; Y S Hong; T W Kim; D H Cho; S Y Kim; Y S Kim
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

9.  Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.

Authors:  Yoon Kyung Jo; Seung Cheol Kim; In Ja Park; So Jung Park; Dong-Hoon Jin; Seung-Woo Hong; Dong-Hyung Cho; Jin Cheon Kim
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Loss of SPRR3 in ApoE-/- mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs.

Authors:  Caressa D Lietman; Amanda K Segedy; Bin Li; Sergio Fazio; James B Atkinson; MacRae F Linton; Pampee P Young
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.